Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application (Research, (Clinical- Cancer, Hematology), Industrial), End User (Biotech, Hospitals) - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
The Latin American flow cytometry market is estimated to register a CAGR of 7.1% to reach USD 379 million by 2027 from USD 269 million in 2022
The growing prevalence of cancer and HIV/ AIDS, growing research activities which adopt flow cytometry techniques, and an increase in the innovation efforts to develop technologically advanced instruments and software are prominently driving the growth of the Latin American Flow cytometry market.
However, the high cost of flow cytometry products such as instruments and consumables, is a major factor that is expected to restrain market growth to a certain extent.
The reagents and consumables subsegment accounted for the highest growth rate in the Latin American Flow Cytometry market, by product & service, during the forecast period
In 2021, the reagents and consumables subsegment accounted for the highest growth rate. Factors such as continuous demand for flow cytometry reagents for diagnostic applications and growing research activities that use flow cytometry techniques are expected to favor the growth of this market.
Mexico: The fastest-growing country in the Latin American Flow cytometry market
The Mexican market is estimated to record the highest CAGR during the forecast period. Favorable trade agreements to support the availability of flow cytometry products in the country and the growth of the pharmaceutical industry are expected to support market growth in the country.
The prominent players in the Latin American flow cytometry market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), and Luminex Corporation (US).
| Report Attribute | Details |
| No. of Pages | 202 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value (USD) in 2022 | $269 Million |
| Forecasted Market Value (USD) by 2027 | $379 Million |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Latin America |
Premium Insights
- Advancements in Flow Cytometry Techniques to Drive Market Growth
- Reagents and Consumables Segment Accounted for Largest Share in 2021
- Cell-Based Flow Cytometry Segment to Dominate Market During Forecast Period
- Academic and Research Institutes Segment to Dominate Market During Forecast Period
Market Dynamics
Drivers
- Increasing Incidence of Cancer and HIV/Aids
- Research Activities Such as Drug Discovery Using Flow Cytometry Techniques
- Use of Flow Cytometry in Regenerative Medicine
- Technological Advancements Such as Multicolor Fluorescence, Compact Design, and Automation in Flow Cytometry Instruments
Restraints
- High Cost of Instruments and Consumables
Opportunities
- Adoption of Recombinant DNA Technology for Antibody Production
- International Collaborations in Biotechnology
Challenges
- Shortage of Well-Trained and Skilled Professionals
Company Profiles
- Agilent Technologies, Inc.
- Apogee Flow Systems Ltd.
- Bd (Becton, Dickinson and Company)
- Biolegend, Inc. (Part of Perkinelmer)
- Biomerieux Sa
- Bio-Rad Laboratories Inc.
- Cytek Biosciences
- Danaher Corporation
- Enzo Biochem, Inc.
- Luminex Corporation (A Diasorin Company)
- Miltenyi Biotec
- Sartorius Ag
- Sony Biotechnology Inc. (A Subsidiary of Sony Group Corporation)
- Sysmex Corporation
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
- Union Biometrica, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/zd7795
Attachment
